Catabasis Pharma (NASDAQ: CATB) reported Q1 EPS of ($0.62), $0.07 better than the analyst estimate of ($0.69).“We are making strong ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE